Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 251-528-5 | CAS number: 33454-82-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin irritation / corrosion: not corrosive (OECD No. 431, EU Method B.40 BIS, GLP compliant, K V1), not irritating (OECD No. 439, EU Method B.46, GLP compliant, K V1).
Eye irritation or serious eye damage: no prediction can be made (OECD No. 437, GLP compliant, K V1), potentially irritant or corrosive to the eye (OECD No. 492, GLP compliant).
Respiratory irritation: no specific study was available.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin corrosion: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 31-August-2016 to 24-October-2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP compliant
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 431 (In Vitro Skin Corrosion: Reconstructed Human Epidermis (RHE) Test Method)
- Version / remarks:
- Adopted 29 July 2016
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: EU Method B.40 BIS (In Vitro Skin Corrosion: Human Skin Model Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Except for the Test Item characterisation which was conducted in an ISO 9000 environment.
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL:
- At room temperature container flushed with nitrogen, desiccated - Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Details on animal used as source of test system:
- Not applicable
- Justification for test system used:
- Recommended test system in international guidelines (OECD and EC).
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiDerm Skin Model EPI-200
- Tissue batch number(s): 24364 Kit M and L
- Source: MatTek Corporation, Ashland, MA, USA
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: All incubations, with the exception of the test item incubation of 3 minutes at room temperature, were carried out at 37.0 ± 1.0°C (actual range 35.6 - 37.3°C).
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: MTT concentrate (5 mg/ml) diluted (1:5) with MTT diluent (supplemented DMEM)
- Incubation time: 3 hours (37°C)
- Spectrophotometer: TECAN Infinite® M200 Pro Plate Reader
- Wavelength: 570nm
FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Viability: OD (540-570) = 1.496+/-0.034 [1.0 - 3.0]
- Barrier function: ET-50 = 6.52 hrs [4.77 - 8.72 hrs]
- Morphology: Functional stratum corneum, viable basal cell layer, and intermediate spinous and granular layers
- Contamination: No contamination (absence of bacteria, fungus and mycoplasma)
NUMBER OF REPLICATE TISSUES: 4 tissues per test item together with a negative control and positive control (2 tissues were used for a 3-minute exposure to Lithium Trifluoromethanesulfonate and two for a 1-hour exposure)
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION: 1
PREDICTION MODEL / DECISION CRITERIA
- The test substance is considered to be corrosive to skin if the viability after 3 minutes exposure is less than 50%, or if the viability after 3 minutes exposure is greater than or equal to 50 % and the viability after 1 hour exposure is less than 15%.
- The test substance is considered to be non-corrosive to skin if the viability after 3 minutes exposure is greater than or equal to 50% and the viability after 1 hour exposure is greater than or equal to 15%. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount applied: 35.6 to 48.6 mg of the solid test item with 25 µl Milli-Q water (Millipore Corp., Bedford, Mass., USA) to ensure close contact of the test item to the tissue.
NEGATIVE CONTROL
- Amount applied: 50 µl Milli-Q water
POSITIVE CONTROL
- Amount applied: 50 µl KOH
- Concentration: 8N - Duration of treatment / exposure:
- 3-minute and 1-hour exposures
- Number of replicates:
- 4 tissues per test item together with a negative control and positive control (2 tissues were used for a 3-minute exposure to Lithium Trifluoromethanesulfonate and two for a 1-hour exposure)
- Irritation / corrosion parameter:
- % tissue viability
- Remarks:
- Mean values
- Run / experiment:
- 3-minute application
- Value:
- 90
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 100%
- Positive controls validity:
- valid
- Remarks:
- 11%
- Remarks on result:
- no indication of irritation
- Irritation / corrosion parameter:
- % tissue viability
- Remarks:
- Mean values
- Run / experiment:
- 1-hour application
- Value:
- 63
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 100%
- Positive controls validity:
- valid
- Remarks:
- 11%
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- ACCEPTANCE OF RESULTS:
The absolute mean OD570 (optical density at 570 nm) of the negative control tissues was within the acceptance limits of OECD 431 (lower acceptance limit >=0.8 and upper acceptance limit <=2.8) and the laboratory historical control data range (3-minute treatment: 1.324-2.615 / 1-hour treatment: 1.361-2.352).
The mean relative tissue viability following the 3-minute or 1-hour exposure to the positive control was 11%.
In the range 20-100% viability, the Coefficient of Variation (cut-off value <= 30%) between tissue replicates was <= 10% for the negative control and the 3-minute treatment with the test item, indicating that the test system functioned properly. For the 1-hour treatment with the test item the coefficient of variation was 69%, but because the individual results of the mean relative tissue were 30% and 97%, both above 15%, this does not affect the study outcome. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Lithium Trifluoromethanesulfonate is not corrosive in the in vitro skin corrosion test (OECD Guideline No. 431, adopted 29 July 2016) under the experimental conditions described in this report.
The substance is not classified as corrosive to skin according to GHS criteria. - Executive summary:
The assessment of the corrosive potential to skin of Lithium Trifluoromethanesulfonate was carried out, under GLP compliance, using an in vitro skin corrosive test based on the guidelines described in: OECD No. 431 (adopted 29 July 2016) and EU Method B.40 BIS.
The test consisted of topical application of Lithium Trifluoromethanesulfonate (35.6 to 48.6 mg of the solid test item with 25 µl Milli-Q water) on the skin tissue for 3-minute and 1-hour. After exposure the skin tissue was thoroughly rinsed to remove the test item followed by immediate determination of the cytotoxic (corrosive) effect.
Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) at the end of the treatment.
The relative mean tissue viability obtained after the 3-minute and 1-hour treatments with Lithium Trifluoromethanesulfonate compared to the negative control tissues was 90% and 63% respectively.
Because the mean relative tissue viability for Lithium Trifluoromethanesulfonate was not below 50% after 3 minutes treatment and not below 15% after 1 hour treatment, Lithium Trifluoromethanesulfonate is considered to be non-corrosive in the performed experiment. The substance is not classified as corrosive to skin according to GHS criteria.
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 30-November-2016 to 17-February-2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP compliant
- Reason / purpose for cross-reference:
- reference to other study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- Adopted 28 July 2015
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Version / remarks:
- Amended by EC No. 640/2012 OJ No. L193, 20 July 2012
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Except for the Test Item characterisation which was conducted in an ISO 9000 environment.
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL:
- At room temperature container flushed with nitrogen, desiccated - Test system:
- human skin model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Justification for test system used:
- In the interest of sound science and animal welfare, a sequential testing strategy is recommended to minimise the need of in vivo testing. One of the validated in vitro skin irritation tests is the EPISKIN test, which is recommended in international guidelines (e.g. OECD and EC).
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EPISKIN Small ModelTM (EPISKIN-SMTM, 0.38 cm2)
- Tissue batch number(s): 17-EKIN-001
- Source: SkinEthic Laboratories, Lyon, France
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: All incubations, with the exception of the test item incubation of 15 minutes at room temperature, were carried out at 37.0 ± 1.0°C (actual range 36.5 - 37.3 °C)
- Temperature of post-treatment incubation: 37.0 °C
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT / EXPOSURE
- MTT concentration: 0.3 mg/mL
- Incubation time: 3 hours (37°C)
- Spectrophotometer: TECAN Infinite® M200 Pro Plate Reader
- Wavelength: 570nm
FUNCTIONAL MODEL CONDITIONS WITH REFERENCE TO HISTORICAL DATA
- Viability: IC50 = 1.8 mg/mL [1.5 - 3.0]
- Morphology: Well-differentiated epidermis consisting of a basal layer, several spinous and granular layers and a thick stratum corneum
- Contamination: No contamination (absence of bacteria, fungus and mycoplasma)
NUMBER OF REPLICATE TISSUES: 3 tissues per test item together with negative and positive controls
NUMBER OF INDEPENDENT TEST SEQUENCES / EXPERIMENTS TO DERIVE FINAL PREDICTION: 1
PREDICTION MODEL / DECISION CRITERIA
- The test substance is considered to be irritant to skin if the relative mean tissue viability of three individual tissues after 15 minutes of exposure and 42 hours post incubation is less than or equal to 50% of the mean viability of the negative controls.
- The test substance is considered to be non-irritant to skin if the relative mean tissue viability of three individual tissues after 15 minutes of exposure and 42 hours post incubation is greater than 50% of the mean viability of the negative controls. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount applied: 14.9 to 15.8 mg of the solid test item with 5 µl Milli-Q water (Millipore Corp., Bedford, Mass., USA) to ensure close contact of the test item to the tissue. - Duration of treatment / exposure:
- 15 ± 0.5 minutes at room temperature
- Duration of post-treatment incubation (if applicable):
- 42 hours at 37°C
- Number of replicates:
- 3
- Irritation / corrosion parameter:
- % tissue viability
- Remarks:
- Mean values
- Value:
- 76
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 100%
- Positive controls validity:
- valid
- Remarks:
- 3.2%
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- ACCEPTANCE OF RESULTS:
The positive control had a mean cell viability after 15 ± 0.5 minutes exposure of 3.2% (<= 50%). The absolute mean OD570 of the negative control tissues was within the laboratory historical control data range. The standard deviation value of the percentage viability of three tissues treated identically was less than 5% (<= 18%), indicating that the test system functioned properly. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- Lithium Trifluoromethanesulfonate is not irritant in the in vitro skin irritation test (OECD Guideline No. 439, adopted 28 July 2015) under the experimental conditions described in this report.
The substance is not classified as irritant to skin according to GHS criteria. - Executive summary:
The assessment of the irritant potential to skin of Lithium Trifluoromethanesulfonate was carried out, under GLP compliance, using an in vitro skin irritation test based on the guidelines described in: OECD No. 439 (adopted 28 July 2015) and EU Method B.46 (Amended by EC No. 640/2012 OJ No. L193, 20 July 2012).
The test consisted of topical application of Lithium Trifluoromethanesulfonate (14.9 to 15.8 mg of the solid test item with 5 µl Milli-Q water) on the skin tissue for 15 minutes. After exposure the skin tissue was thoroughly rinsed to remove the test item and transferred to fresh medium. After a 42 hour incubation period, determination of the cytotoxic (irritancy) effect was performed.
Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) at the end of the treatment.
The relative mean tissue viability obtained after the 15 -minute treatment with Lithium Trifluoromethanesulfonate compared to the negative control tissues was 76%.
Since the mean relative tissue viability for the test item was above 50%, Lithium Trifluoromethanesulfonate is considered to be non-irritant. The substance is not classified as irritant to skin according to GHS criteria.
Finally, Lithium Trifluoromethanesulfonate is non-irritant in the in vitro skin irritation test under the experimental conditions described in this report and should not be classified according to the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) of the United Nations based on this test and the in vitro skin corrosion study (project 514504).
Referenceopen allclose all
Preliminary tests
Lithium Trifluoromethanesulfonate was checked for colour interference in aqueous conditions and possible direct MTT reduction by adding the test item to MTT medium. Because the solutions did not turn blue/purple nor a blue/purple precipitate was observed it was concluded that Lithium Trifluoromethanesulfonate did not interfere with the MTT endpoint.
Main test
The mean absorption at 570 nm measured after treatment with Lithium Trifluoromethanesulfonate and controls are presented in the following Table. The individual OD570 measurements are presented in an other Table below.
Mean absorption in the in vitro skin corrosion test with Lithium Trifluoromethanesulfonate
3 -minute application | 1 -hour application | |||||||||
A (OD570) |
B (OD570) |
Mean (OD570) |
|
SD |
A (OD570) |
B (OD570) |
Mean (OD570) |
|
SD |
|
Negative control |
1.526 |
1.586 |
1.556 |
+/- |
0.042 |
1.770 |
1.588 |
1.679 |
+/- |
0.129 |
Lithium Trifluoromethanesulfonate |
1.440 |
1.372 |
1.406 |
+/- |
0.048 |
0.502 |
1.626 |
1.064 |
+/- |
0.795 |
Positive control |
0.180 |
0.155 |
0.167 |
+/- |
0.018 |
0.205 |
0.163 |
0.184 |
+/- |
0.030 |
SD= Standard deviation
Duplicate exposures are indicated by A and B
In this table the values are corrected for background absorption (0.0420). Isopropanol was used to measure the background absorption.
Individual OD measurements at 570 nm
3-minute application (OD570) AB |
1-hour application (OD570) AB |
|||
Negative control |
|
|
||
OD570 measurement 1 |
1.5361 |
1.6025 |
1.7973 |
1.6268 |
OD570 measurement 2 |
1.5801 |
1.6369 |
1.8098 |
1.6275 |
OD570 measurement 3 |
1.5880 |
1.6449 |
1.8278 |
1.6348 |
Lithium Trifluoromethanesulfonate |
|
|
|
|
OD570 measurement 1 |
1.5015 |
1.4262 |
0.5481 |
1.6941 |
OD570 measurement 2 |
1.4688 |
1.4062 |
0.5456 |
1.6541 |
OD570 measurement 3 |
1.4750 |
1.4106 |
0.5380 |
1.6556 |
Positive control |
|
|
|
|
OD570 measurement 1 |
0.2226 |
0.2013 |
0.2484 |
0.2051 |
OD570 measurement 2 |
0.2199 |
0.1948 |
0.2513 |
0.2053 |
OD570 measurement 3 |
0.2221 |
0.1934 |
0.2425 |
0.2051 |
OD = Optical density
Duplicate exposures are indicated by A and B.
The following Table shows the mean tissue viability obtained after 3-minute and 1-hour treatments with Lithium Trifluoromethanesulfonate compared to the negative control tissues.
3-minute application Viability, percentage of control |
1 -hour application Viability, percentage of control |
|
Negative control |
100 (98 and 102) / SD: 3.8 |
100 (105 and 95) / SD: 10.3 |
Lithium Trifluoromethanesulfonate |
90 (93 and 88) / SD: 4.7 |
63 (30 and 97) / SD: 69.1 |
Positive control |
11 (12 and 10) / SD: 13.9 |
11 (12 and 10) / SD: 20.6 |
SD= Standard deviation
Skin corrosion is expressed as the remaining cell viability after exposure to the test item. The relative mean tissue viability obtained after the 3-minute and 1-hour treatments with Lithium Trifluoromethanesulfonate compared to the negative control tissues was 90% and 63% respectively. Because the mean relative tissue viability for Lithium Trifluoromethanesulfonate was not below 50% after 3 minutes treatment and not below 15% after 1 hour treatment, Lithium Trifluoromethanesulfonate is considered to be not corrosive.
The mean absorption at 570 nm measured after treatment with Lithium Trifluoromethanesulfonate and controls are presented in the following Table. The individual OD570 measurements are presented in an other Table below.
Mean absorption in the in vitro skin irritation test with Lithium Trifluoromethanesulfonate
A (OD570) |
B (OD570) |
C (OD570) |
Mean (OD570) |
SD | ||
Negative control | 1.002 | 0.971 | 0.917 | 0.963 | +/- | 0.043 |
Lithium Trifluoromethanesulfonate | 0.729 | 0.745 | 0.723 | 0.732 | +/- | 0.012 |
Positive control | 0.030 | 0.038 | 0.032 | 0.030 | +/- | 0.007 |
OD= optical density
SD= standard deviation
Triplicate exposures are indicated by A, B and C.
In this table the values are corrected for background absorption (0.042). Isopropanol was used to measure the background absorption.
Individual OD measurements at 570 nm
A (OD570) |
B (OD570) |
C (OD570) |
|
Negative control |
|
|
|
OD570 measurement 1 |
1.0533 |
1.1062 |
0.9533 |
OD570 measurement 2 |
1.0361 |
0.9211 |
0.9649 |
Lithium Trifluoromethanesulfonate |
|
|
|
OD570 measurement 1 |
0.7764 |
0.7791 |
0.8263 |
OD570 measurement 2 |
0.7671 |
0.7966 |
0.7040 |
Positive control |
|
|
|
OD570 measurement 1 |
0.0685 |
0.0870 |
0.0650 |
OD570 measurement 2 |
0.0765 |
0.0739 |
0.0663 |
OD= optical density
Triplicate exposures are indicated by A, B and C.
The following Table shows the mean tissue viability obtained after 15 ± 0.5 minutes treatment with the test item compared to the negative control tissues.
Mean tissue viability (percentage of control) |
Standard deviation (percentage) |
|
Negative control | 100 | 4.5 |
Lithium Trifluoromethanesulfonate | 76 | 1.2 |
Positive control | 3.2 | 0.8 |
Skin irritation is expressed as the remaining cell viability after exposure to the test item. The relative mean tissue viability obtained after 15 ± 0.5 minutes treatment with the test item compared to the negative control tissues was 76%. Since the mean relative tissue viability for the test item was above 50%, the test item is considered to be non-irritant in the performed experiment.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 29-August-2016 to 21-October-2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP compliant
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 437 (Bovine Corneal Opacity and Permeability Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- Adopted July 26, 2013
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL:
- At room temperature container flushed with nitrogen, desiccated - Species:
- cattle
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- SOURCE OF COLLECTED EYES
- Source: Bovine eyes obtained from the slaughterhouse (Vitelco, -'s Hertogenbosch, The Netherlands), where the eyes were excised by a slaughterhouse employee as soon as possible after slaughter.
- Characteristics of donor animals: Young cattle
- Storage, temperature and transport conditions of ocular tissue: Eyes were collected and transported in physiological saline in a suitable container under cooled conditions. - Vehicle:
- physiological saline
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- A 20% (w/v) solution of Lithium Trifluoromethanesulfonate was prepared in physiological saline
- Duration of treatment / exposure:
- 240 +/- 10 minutes at 32 +/- 1°C
- Duration of post- treatment incubation (in vitro):
- 90 minutes incubation period with sodium fluorescein
- Number of animals or in vitro replicates:
- 3 corneas per treatment group
- Details on study design:
- PREPARATION OF CORNEAS
The eyes were checked for unacceptable defects, such as opacity, scratches, pigmentation and neovascularization by removing them from the physiological saline and holding them in the light. Those exhibiting defects were discarded.
The isolated corneas were stored in a petri dish with cMEM (Earle’s Minimum Essential Medium (Life Technologies, Bleiswijk, The Netherlands) containing 1% (v/v) L-glutamine (Life Technologies) and 1% (v/v) Foetal Bovine Serum (Life Technologies)). The isolated corneas were mounted in a corneal holder (one cornea per holder) of BASF (Ludwigshafen, Germany) with the endothelial side against the O-ring of the posterior half of the holder. The anterior half of the holder was positioned on top of the cornea and tightened with screws. The compartments of the corneal holder were filled with cMEM of 32 +/- 1°C. The corneas were incubated for the minimum of 1 hour at 32 +/- 1°C.
CORNEA SELECTION AND OPACITY READING
After the incubation period, the medium was removed from both compartments and replaced with fresh cMEM. Opacity determinations were performed on each of the corneas using an opacitometer (BASF-OP3.0, BASF, Ludwigshafen, Germany). The opacity of each cornea was read against a cMEM filled chamber, and the initial opacity reading thus determined was recorded. Corneas that had an initial opacity reading higher than 7 were not used. Three corneas were selected at random for each treatment group.
TREATMENT OF CORNEAS AND OPACITY MEASUREMENTS
The medium from the anterior compartment was removed and 750 µl of either the negative control, positive control (20% (w/v) Imidazole solution) or 20% (w/v) solution of the test item was introduced onto the epithelium of the cornea. The holder was slightly rotated, with the corneas maintained in a horizontal position, to ensure uniform distribution of the solutions over the entire cornea.
Corneas were incubated in a horizontal position for 240 +/- 10 minutes at 32 +/- 1°C. After the incubation the solutions were removed and the epithelium was washed at least three times with MEM with phenol red (Earle’s Minimum Essential Medium Life Technologies). Possible pH effects of the test item on the corneas were recorded. Each cornea was inspected visually for dissimilar opacity patterns. The medium in the posterior compartment was removed and both compartments were refilled with fresh cMEM and the opacity determinations were performed.
OPACITY MEASUREMENT
The opacity of a cornea was measured by the diminution of light passing through the cornea. The light was measured as illuminance (I = luminous flux per area, unit: lux) by a light meter. The opacity value (measured with the device OP-KIT) was calculated according to:
Opacity = [(I0/I) − 0.9894] / 0.0251
With I0 the empirically determined illuminance through a cornea holder but with windows and medium, and I the measured illuminance through a holder with cornea. The change in opacity for each individual cornea (including the negative control) was calculated by subtracting the initial opacity reading from the final post-treatment reading. The corrected opacity for each treated cornea with the test item or positive control was calculated by subtracting the average change in opacity of the negative control corneas from the change in opacity of each test item or positive control treated cornea. The mean opacity value of each treatment group was calculated by averaging the corrected opacity values of the treated corneas for each treatment group.
APPLICATION OF SODIUM FLUORESCEIN
Following the final opacity measurement, permeability of the cornea to Na-fluorescein (Sigma-Aldrich, Germany) was evaluated. The medium of both compartments (anterior compartment first) was removed. The posterior compartment was refilled with fresh cMEM. The anterior compartment was filled with 1 ml of 5 mg Na-fluorescein/ml cMEM solution (Sigma-Aldrich Chemie GmbH, Germany). The holders were slightly rotated, with the corneas maintained in a horizontal position, to ensure uniform distribution of the sodium-fluorescein solution over the entire cornea. Corneas were incubated in a horizontal position for 90 +/- 5 minutes at 32 +/- 1°C.
PERMEABILITY DETERMINATIONS
After the incubation period, the medium in the posterior compartment of each holder was removed and placed into a sampling tube labelled according to holder number. 360 µl of the medium from each sampling tube was transferred to a 96-well plate. The optical density at 490 nm (OD490) of each sampling tube was measured in triplicate using a microplate reader (TECAN Infinite® M200 Pro Plate Reader). Any OD490 that was 1.500 or higher was diluted to bring the OD490 into the acceptable range (linearity up to OD490 of 1.500 was verified before the start of the experiment). OD490 values of less than 1.500 were used in the permeability calculation.
The mean OD490 for each treatment was calculated using cMEM corrected OD490 values. If a dilution has been performed, the OD490 of each reading of the positive control and the test item was corrected for the mean negative control OD490 before the dilution factor was applied to the reading.
SCORING SYSTEM: In Vitro Irritancy Score (IVIS)
The mean opacity and mean permeability values (OD490) were used for each treatment group to calculate an in vitro score:
In vitro irritancy score (IVIS) = mean opacity value + (15 x mean OD490 value)
Additionally the opacity and permeability values were evaluated independently to determine whether the test item induced irritation through only one of the two endpoints.
DECISION CRITERIA:
The IVIS cut-off values for identifying the test items as inducing serious eye damage (UN GHS Category 1) and test items not requiring classification for eye irritation or serious eye damage (UN GHS No Category), as described in the OECD Guideline No. 437, are given hereafter:
In vitro score range: UN GHS:
≤ 3 No Category
> 3 ; ≤ 55 No prediction can be made
> 55 Category 1 - Irritation parameter:
- in vitro irritation score
- Remarks:
- Mean values
- Value:
- 7
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- -0.1
- Positive controls validity:
- valid
- Remarks:
- 102.9
- Remarks on result:
- other: No prediction can be made
- Other effects / acceptance of results:
- ACCEPTANCE OF RESULTS:
The negative control responses for opacity and permeability were less than the upper limits of the laboratory historical range indicating that the negative control did not induce irritancy on the corneas. The mean in vitro irritancy score of the positive control (20% (w/v) Imidazole) was 103 and within two standard deviations of the current historical positive control mean. It was therefore concluded that the test conditions were adequate and that the test system functioned properly. - Interpretation of results:
- study cannot be used for classification
- Conclusions:
- Evaluation of the eye hazard potential of Lithium Trifluoromethanesulfonate using the Bovine Corneal Opacity and Permeability test (BCOP test, OECD Guideline No. 437).
The test item induced ocular irritation through both endpoints, resulting in a mean in vitro irritancy score of 7.0 after 240 minutes of treatment.
Since Lithium Trifluoromethanesulfonate induced an IVIS > 3 ≤ 55, no prediction on the classification can be made. - Executive summary:
The assessment of the eye hazard potential of Lithium Trifluoromethanesulfonate was carried out, under GLP compliance, using the Bovine Corneal Opacity and Permeability test (BCOP test) based on the OECD Guideline No. 437 (adopted 26 July 2013).
The test consisted of topical application of Lithium Trifluoromethanesulfonate on the epithelium of the bovine cornea for 4 hours. The non-surfactant solid test item was applied as a 20% solution. After exposure the corneas were thoroughly rinsed. The opacity of the corneas was determined directly after treatment and the permeability of the corneas was determined after a 90 minutes incubation period with sodium fluorescein.
The negative control responses for opacity and permeability were less than the upper limits of the laboratory historical range indicating that the negative control did not induce irritancy on the corneas. The mean in vitro irritancy score of the positive control (20% (w/v) Imidazole) was 103 and within two standard deviations of the current historical positive control mean. It was therefore concluded that the test conditions were adequate and that the test system functioned properly. Lithium Trifluoromethanesulfonate induced ocular irritation through both endpoints, resulting in a mean in vitro irritancy score of 7.0 after 240 minutes of treatment. Since Lithium Trifluoromethanesulfonate induced an IVIS > 3 ≤ 55, no prediction on the classification can be made.
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 30-November-2016 to 14-February-2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- GLP compliant
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- Adopted 28 July 2015
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Except for the Test Item characterisation which was conducted in an ISO 9000 environment.
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL:
- At room temperature container flushed with nitrogen, desiccated - Species:
- human
- Details on test animals or tissues and environmental conditions:
- - Justification of the test method and considerations regarding applicability: In the interest of sound science and animal welfare, a sequential testing strategy is recommended to minimise the need of in vivo testing. One of the validated in vitro eye irritation tests is the EpiOcular test, which is recommended in international guidelines and scientific publications (e.g. OECD).
- Description of the cell system used, incl. certificate of authenticity and the mycoplasma status of the cell live: EpiOcular™ (OCL-200-EIT MatTek Corporation, Lot: 23460 kit J, supplied by MatTek Corporation, Ashland MA, U.S.A.)
The EpiOcular tissue construct is a non-keratinized epithelium (0.6 cm2) prepared from normal human keratinocytes (MatTek). It models the cornea epithelium with progressively stratified, but not cornified cells. These cells are not transformed or transfected with genes to induce an extended life span in culture. The “tissue” is prepared in inserts with a porous membrane through which the nutrients pass to the cells. A cell suspension is seeded into the insert in specialized medium. After an initial period of submerged culture, the medium is removed from the top of the tissue so that the epithelial surface is in direct contact with the air. This allows the test material to be directly applied to the epithelial surface in a fashion similar to how the corneal epithelium would be exposed in vivo.
The cells used to produce EpiOcular tissue are screened for potential biological contaminants. Tests performed for each of the potential biological contaminants listed (HIV-1 virus, Hepatitis B virus, Hepatitis C virus, Bacteria, yeast and other fungi) were performed according to standardised test methods. The product resulted in "no detection" for the potential biological contaminants previously listed. - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- 56.8 to 57.6 mg of the test item applied directly on top of the skin tissue
- Duration of treatment / exposure:
- 6 hours ± 15 minutes at 37.0 ± 1.0°C
- Duration of post- treatment incubation (in vitro):
- 18 hours ± 15 minutes at 37°C
- Number of animals or in vitro replicates:
- 2 tissues per test item together with a negative control and positive control
- Irritation parameter:
- other: Tissue viability (percentage of control)
- Remarks:
- Mean values
- Value:
- 2.4
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 100%
- Positive controls validity:
- valid
- Remarks:
- 22%
- Remarks on result:
- other: Potentially irritant or corrosive
- Other effects / acceptance of results:
- ACCEPTANCE OF RESULTS:
The positive control had a mean cell viability after 6 hours ± 15 minutes exposure of 22% (< 50%). The absolute mean OD570 of the negative control tissues was within 0.8 and 2.5. The standard deviation value of the percentage viability of two tissues treated identically was less than 13% (< 50%), indicating that the test system functioned properly. Acceptance criteria were met. - Interpretation of results:
- other: UN GHS Category 1 or 2
- Conclusions:
- The mean relative tissue viability for the test item was below 60% it is considered to be potentially irritant or corrosive to the eye.
Lithium Trifluoromethanesulfonate is potentially irritant or corrosive in the EpiOcular™ test under the experimental conditions described in this report. - Executive summary:
The assessment of the eye hazard potential of Lithium Trifluoromethanesulfonate was carried out, under GLP compliance, using the EpiOcular™ test based on the OECD Guideline No. 492 (adopted 28 July 2015).
The test consisted of topical application of Lithium Trifluoromethanesulfonate on the Reconstructed Human EpiOcular™ Model for 6 hours. The solid test item was directly applied. After exposure the cornea epithelial construct was thoroughly rinsed to remove the test item and transferred to fresh medium for an immersion incubation. Afterwards, the tissues were transferred to fresh medium and incubated for 18 hours at standard culture conditions, prior to determination of the cytotoxic (irritancy) effect
The positive control had a mean cell viability of 22% after 6 hours ± 15 minutes exposure. The absolute mean OD570 (optical density at 570 nm) of the negative control tissues was within 0.8 and 2.5. The standard deviation value of the percentage viability of two tissues treated identically was less than 13%, indicating that the test system functioned properly.
Eye hazard potential is expressed as the remaining cell viability after exposure to the test item. The relative mean tissue viability obtained after 6 hours ± 15 minutes treatment with the test item compared to the negative control tissues was 2.4%. Since the mean relative tissue viability for the test item was below or equal to 60% after 6 hours ± 15 minutes treatment it is considered to be potentially irritant or corrosive to the eye.
Lithium Trifluoromethanesulfonate is potentially irritant or corrosive in the EpiOcular™ test under the experimental conditions described in this report. According to the UN GHS Regulation, based on the results of this test, the test substance is classified in Category 1 or 2. The EpiOcular™ test based on the OECD Guideline No. 492 do not allow to classify according to the Regulation (EC) 1272/2008 (CLP).
Referenceopen allclose all
Lithium Trifluoromethanesulfonate was tested in a 20% (w/v) solution.
The opacity, permeability and in vitro scores of the individual corneas are shown in the following Tables:
Individual opacity scores
Treatment | Opacity before treatment | Opacity after treatment | Final opacity1 | Negative control corrected Final Opacity2 | Mean Final Opacity |
Negative control | 3.9 | 4.2 | 0.3 | -0.2 | |
2.3 | 2.3 | 0.0 | |||
2.3 | 1.5 | -0.8 | |||
Positive control | 2.6 | 76.9 | 74.3 | 74.3 | 75.3 |
2.9 | 62.5 | 59.6 | 59.6 | ||
3.9 | 96.0 | 92.1 | 92.1 | ||
Test item | 2.5 | 9.3 | 6.8 | 6.8 | 6.5 |
2.9 | 10.6 | 7.7 | 7.7 | ||
3.9 | 8.4 | 5.0 | 5.0 |
1 Final Opacity = Opacity after treatment – Opacity before treatment.
2 Negative control corrected Final Opacity = Final opacity – Mean final opacity negative control3
3 In case the mean final opacity of the negative control is below zero, no correction will be made.
Permeability score individual values (uncorrected)
Treatment | Dilution factor | OD490 1 |
OD490 2 |
OD490 3 |
Average OD |
Final OD | Mean Final negative control |
Negative control | 1 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | -0.2 |
1 | 0.001 | 0.012 | 0.002 | 0.005 | 0.005 | ||
1 | 0.005 | 0.005 | 0.006 | 0.005 | 0.005 | ||
Positive control | 1 | 1.028 | 1.042 | 1.010 | 1.027 | 1.027 | |
6 | 0.552 | 0.545 | 0.535 | 0.545 | 3.270 | ||
1 | 1.257 | 1.250 | 1.257 | 1.255 | 1.255 | ||
Test item | 1 | 0.023 | 0.012 | 0.022 | 0.019 | 0.019 | |
1 | 0.009 | 0.010 | 0.011 | 0.010 | 0.010 | ||
1 | 0.079 | 0.072 | 0.080 | 0.077 | 0.077 |
Permeability score individual values (corrected)
Treatment | Dilution factor | Negative control corrected OD490 11 |
Negative control corrected OD490 21 |
Negative control corrected OD490 31 |
Negative control corrected OD490 Average |
Negative control corrected Final OD490 |
Average OD |
Positive control | 1 | 1.023 | 1.037 | 1.005 | 1.022 | 1.022 | 1.838 |
6 | 0.547 | 0.540 | 0.533 | 0.540 | 3.241 | ||
1 | 1.252 | 1.245 | 1.252 | 1.250 | 1.250 | ||
Test item | 1 | 0.018 | 0.007 | 0.017 | 0.014 | 0.014 | 0.031 |
1 | 0.004 | 0.005 | 0.006 | 0.005 | 0.005 | ||
1 | 0.074 | 0.067 | 0.075 | 0.072 | 0.072 |
1 OD490 values corrected for the mean final negative control permeability (0.005).
In Vitro irritancy score
Treatment | Final Opacity2 | Final OD4902 | In vitroIrritancy Score1 |
Negative control | 0.3 | 0.004 | 0.4 |
0.0 | 0.005 | 0.0 | |
-0.8 | 0.005 | -0.7 | |
Positive control | 74.3 | 1.022 | 89.6 |
59.6 | 3.241 | 108.2 | |
92.1 | 1.250 | 110.9 | |
Test item | 6.8 | 0.014 | 7.1 |
7.7 | 0.005 | 7.7 | |
5.0 | 0.072 | 6.1 |
1 In vitro irritancy score (IVIS) = opacity value + (15 x OD490 value).
2 Positive control and test item are corrected for the negative control.
The individual in vitro irritancy scores for the negative controls ranged from -0.7 to 0.4. The individual positive control in vitro irritancy scores ranged from 89.6 to 110.9. The corneas treated with the positive control were turbid after the 240 minutes of treatment.
The corneas treated with Lithium Trifluoromethanesulfonate showed opacity values ranging from 5.0 to 7.7 and permeability values ranging from 0.005 to 0.072. The corneas were translucent after the 240 minutes of treatment with Lithium Trifluoromethanesulfonate. No pH effect of the test item was observed on the rinsing medium. Hence, the in vitro irritancy scores ranged from 6.1 to 7.7 after 240 minutes of treatment with Lithium Trifluoromethanesulfonate.
Since Lithium Trifluoromethanesulfonate induced an IVIS > 3 ≤ 55, no prediction on the classification can be made.
Preliminary tests
Lithium Trifluoromethanesulfonate was checked for colour interference in aqueous conditions and possible direct MTT reduction by adding the test item to MTT medium. Because the solutions did not turn blue/purple nor a blue/purple precipitate was observed it was concluded that Lithium Trifluoromethanesulfonate did not interfere with the MTT endpoint.
Main test
The following Table shows the mean tissue viability obtained after 6 hours ± 15 minutes treatment with the test item compared to the negative control tissues.
Mean tissue viability in the EpiOcular™ test with Lithium Trifluoromethanesulfonate
Mean tissue viability (percentage of control) | Standard deviation (percentage) | |
Negative control |
100 | 13 |
Test item | 2.4 | 0.02 |
Positive control | 22 | 5.3 |
Eye hazard potential is expressed as the remaining cell viability after exposure to the test item. The relative mean tissue viability obtained after 6 hours ± 15 minutes treatment with the test item compared to the negative control tissues was 2.4%.
Since the mean relative tissue viability for the test item was below 60%,it is considered to be potentially irritant or corrosive to the eye.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin irritation / corrosion:
Two key studies were identified for skin irritation / corrosion.
The assessment of the corrosive potential to skin of Lithium Trifluoromethanesulfonate was carried out, under GLP compliance, using an in vitro skin corrosive test based on the guidelines described in: OECD No. 431 (adopted 29 July 2016) and EU Method B.40 BIS.
The test consisted of topical application of Lithium Trifluoromethanesulfonate (35.6 to 48.6 mg of the solid test item with 25 µl Milli-Q water) on the skin tissue for 3-minute and 1-hour. After exposure the skin tissue was thoroughly rinsed to remove the test item followed by immediate determination of the cytotoxic (corrosive) effect. Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) at the end of the treatment.
The relative mean tissue viability obtained after the 3-minute and 1-hour treatments with Lithium Trifluoromethanesulfonate compared to the negative control tissues was 90% and 63% respectively. Because the mean relative tissue viability for Lithium Trifluoromethanesulfonate was not below 50% after 3 minutes treatment and not below 15% after 1 hour treatment, Lithium Trifluoromethanesulfonate is considered to be non-corrosive. The substance is not classified as corrosive to skin according to GHS criteria.
The assessment of the irritant potential to skin of Lithium Trifluoromethanesulfonate was carried out, under GLP compliance, using an in vitro skin irritation test based on the guidelines described in: OECD No. 439 (adopted 28 July 2015) and EU Method B.46 (Amended by EC No. 640/2012 OJ No. L193, 20 July 2012).
The test consisted of topical application of Lithium Trifluoromethanesulfonate (14.9 to 15.8 mg of the solid test item with 5 µl Milli-Q water) on the skin tissue for 15 minutes. After exposure the skin tissue was thoroughly rinsed to remove the test item and transferred to fresh medium. After a 42 hour incubation period, determination of the cytotoxic (irritancy) effect was performed. Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) at the end of the treatment.
The relative mean tissue viability obtained after the 15 -minute treatment with Lithium Trifluoromethanesulfonate compared to the negative control tissues was 76%. Since the mean relative tissue viability for the test item was above 50%, Lithium Trifluoromethanesulfonate is considered to be non-irritant. The substance is not classified as irritant to skin according to GHS criteria.
Eye irritation or serious eye damage:
Two key studies were identified for eye irritation.
The assessment of the eye hazard potential of Lithium Trifluoromethanesulfonate was carried out, under GLP compliance, using the Bovine Corneal Opacity and Permeability test (BCOP test) based on the OECD Guideline No. 437 (adopted 26 July 2013).
The test consisted of topical application of Lithium Trifluoromethanesulfonate on the epithelium of the bovine cornea for 4 hours. The non-surfactant solid test item was applied as a 20% solution. After exposure the corneas were thoroughly rinsed. The opacity of the corneas was determined directly after treatment and the permeability of the corneas was determined after a 90 minutes incubation period with sodium fluorescein. The negative control responses for opacity and permeability were less than the upper limits of the laboratory historical range indicating that the negative control did not induce irritancy on the corneas. The mean in vitro irritancy score of the positive control (20% (w/v) Imidazole) was 103 and within two standard deviations of the current historical positive control mean. It was therefore concluded that the test conditions were adequate and that the test system functioned properly.
Lithium Trifluoromethanesulfonate induced ocular irritation through both endpoints, resulting in a mean in vitro irritancy score of 7.0 after 240 minutes of treatment. Since Lithium Trifluoromethanesulfonate induced an IVIS > 3 ≤ 55, no prediction on the classification can be made.
The assessment of the eye hazard potential of Lithium Trifluoromethanesulfonate was carried out, under GLP compliance, using the EpiOcular™ test based on the OECD Guideline No. 492 (adopted 28 July 2015).
The test consisted of topical application of Lithium Trifluoromethanesulfonate on the Reconstructed Human EpiOcular™ Model for 6 hours. The solid test item was directly applied. After exposure the cornea epithelial construct was thoroughly rinsed to remove the test item and transferred to fresh medium for an immersion incubation. Afterwards, the tissues were transferred to fresh medium and incubated for 18 hours at standard culture conditions, prior to determination of the cytotoxic (irritancy) effect. The positive control had a mean cell viability of 22% after 6 hours ± 15 minutes exposure. The absolute mean OD570 (optical density at 570 nm) of the negative control tissues was within 0.8 and 2.5. The standard deviation value of the percentage viability of two tissues treated identically was less than 13%, indicating that the test system functioned properly.
Eye hazard potential is expressed as the remaining cell viability after exposure to the test item. The relative mean tissue viability obtained after 6 hours ± 15 minutes treatment with the test item compared to the negative control tissues was 2.4%. Since the mean relative tissue viability for the test item was below or equal to 60% after 6 hours ± 15 minutes treatment it is considered to be potentially irritant or corrosive to the eye.
Lithium Trifluoromethanesulfonate is potentially irritant or corrosive in the EpiOcular™ test under the experimental conditions described in this report.
Justification for classification or non-classification
Lithium Trifluoromethanesulfonate is non-irritant in the in vitro skin irritation test under the experimental conditions described in the report and should not be classified for skin irritation according to the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) of the United Nations based on the in vitro irritation test and the in vitro skin corrosion study (No classification).
Lithium Trifluoromethanesulfonate cannot be classified based on the results of the BCOP test. However, based on the results of the EpiOcular™ test, the test substance requires classification for eye irritation or serious eye damage (UN GHS Category 1 or 2). Therefore, based on the low IVIS obtained with the BCOP test, Lithium trifluoromethanesulfonate is classified H319: Causes serious eye irritation (Category 2) according to the Regulation (EC) 1272/2008 (CLP).
No study are available for the respiratory irritation assessment.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.